FDA 483 - Eli Lilly Kinsale Ltd.

Eli Lilly Kinsale Limited, a drug substance manufacturer in Kinsale, County Cork, Ireland, was cited for three observations during an FDA inspection. The firm demonstrated inadequate controls to prevent microbial contamination, had insufficient data to support product quality after bioburden excursions, and used a clarity testing method that did not meet European Pharmacopeia requirements. These issues indicate significant concerns regarding manufacturing process control, data integrity, and quality control testing.